The Latest
The WasteWatcherUSPS Needs to Pause Implementation and Deliver Answers to Questions About the Delivering for America Plan
Implementation of the USPS Delivering for American plan must be paused until key questions are answered.
The WasteWatcherFDA Has Once Again Delayed Its Menthol Ban
A federal flavor ban is clearly unpopular and would create black markets.
State ActionCCAGW Urges Minnesota Legislators to Remove 340B Mandate from S.F. 4942
SF 4942's manufacturer mandate would change how the federal 340B drug pricing program operates in Minnesota.
Letters to OfficialsCCAGW Leads Coalition Supporting H.R. 8051, the Earmark Elimination Act
H.R. 8051 would create a permanent ban on earmarks in the House of Representatives.
State ActionCCAGW Urges Vermont Senators to Oppose H. 121
H. 121 will fail to achieve its objective of protecting consumer privacy
The WasteWatcherSouthern States Advance Harmful Tobacco Legislation
Pre-market application requirements for THR products injure public health and finances.
Agency CommentsCAGW Submits Ex Parte Presentation for April 10 meeting with Commissioner Gomez
The WasteWatcherFTC Votes to Unilaterally Ban Non-Compete Agreements
The FTC is once again overreaching its legal authority by voting to ban non-compete agreements.
The WasteWatcherJoint Strike Fighter: Costing More and Flying Less
A new GAO report indicates the F-35 Joint Strike Fighter is costing more and flying less.
The WasteWatcherBan on Bulk Billing Is Bad for Consumers
The FCC Chair is considering a ban on bulk billing for broadband in another effort to fix what is not broken.
The WasteWatcherRecognizing and Protecting Medical Invention and Innovation on World IP Day
There is nothing more important to strengthening innovation than protecting and promoting intellectual property in healthcare.
State ActionCCAGW Urges Kansas Senate Ways and Means Committee to Accept the 340B Amendment
The Kansas House Appropriations Committee’s amendment to Substitute for SB514 eliminates proposed changes to the federal 340B drug pricing program.
